Correlation of Preoperative Gastric Residual Volume With Body Mass Index and Aspiration Risk in Laparoscopic Bariatric Surgery
The Correlation of Gastric Residual Volume Detected by Preoperative Gastric Ultrasonography With Body Mass Index and Aspiration Risk in Patients Undergoing Laparoscopic Bariatric Surgery
1 other identifier
observational
60
1 country
1
Brief Summary
Obesity is a chronic, complex disease defined by the World Health Organization (WHO) as the excessive accumulation of fat in the body that can harm health. Since 1975, the prevalence of obesity has been increasing worldwide, making it a significant public health issue. Body mass index (BMI) is important in diagnosing obesity. BMI is calculated by dividing a person's weight (kg) by the square of their height (m²). BMI: weight (kg) / height² (m²). According to the WHO, a BMI between 30.0-34.9 kg/m² is classified as Class 1 obesity, between 35.0-39.9 kg/m² as Class 2 obesity, between 40-49.9 kg/m² as Class 3 obesity, and ≥50.0 kg/m² as super obesity. Obesity is closely related to increasing morbidity and mortality worldwide, and in obese patients, the incidence of diseases such as type 2 diabetes, hypertension, cardiovascular disease, dyslipidemia, coronary heart disease, obstructive sleep apnea, asthma, depression, other psychiatric disorders, and gastroesophageal reflux has increased. Treatment options for obesity include lifestyle changes, specific diets, diet-drug combinations, metabolic and various bariatric surgical options. Among these treatment options, metabolic and bariatric surgical procedures are considered the most effective methods for weight loss. Aspiration of gastric contents is a significant perioperative complication that can cause up to 9% of anesthesia-related deaths. Due to delayed gastric emptying in obese patients, the risk of aspiration is higher compared to non-obese patients. In obese patients, preoperative anesthesia management is more challenging, and the risk of pulmonary aspiration is greater. Since obesity is an independent risk factor for patients with a full stomach, and airway management can be difficult in these patients, it is essential to assess the aspiration risk in the preoperative period. Anesthesia guidelines recommend that to improve the quality and effectiveness of anesthesia care and reduce the severity of potential complications related to perioperative pulmonary aspiration of gastric contents, adults and children should be allowed to drink clear liquids up to 2 hours before elective surgery, and solid food consumption should be prohibited 6 hours before elective surgery. Recently, with the integration of ultrasound into anesthesia practice, ultrasound has been applied in various surgical procedures and clinical conditions. The use of ultrasound to evaluate the risk of aspiration in the preoperative period and to determine the residual gastric volume is increasingly being used in clinical practice. The use of gastric ultrasound to assess aspiration risk has also been increasing in pediatric patient groups and pregnant patients, similar to obese patient groups. In this study, the investigators' aim is to determine the relationship between BMI, fasting duration, and aspiration risk by assessing the gastric residual volume in the preoperative period through gastric ultrasonography in patients with obesity who will undergo bariatric surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
May 19, 2025
CompletedFirst Posted
Study publicly available on registry
June 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2026
CompletedJune 22, 2025
June 1, 2025
1.5 years
May 19, 2025
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The correlation between BMI, gastric residual volume, and aspiration risk.
Higher BMI levels may be associated with increased gastric residual volume (GRV), which in turn can elevate the risk of pulmonary aspiration, especially during anesthesia. Understanding the correlation between BMI, GRV, and aspiration risk is crucial for developing safer preoperative fasting guidelines and optimizing care in high-risk patients.
5 minutes
Secondary Outcomes (1)
The correlation between fasting duration, gastric residual volume, and the risk of aspiration
5 minutes
Eligibility Criteria
Patients who will undergo bariatric surgery under general anesthesia in elective conditions
You may qualify if:
- Patients who will undergo bariatric surgery under general anesthesia in elective conditions
- Patients in ASA II-III groups, with BMI \> 35 kg/m², and aged between 18-65 years
- Patients who have provided informed consent
You may not qualify if:
- Patients under 18 years of age, over 65 years of age, or in ASA IV-V groups
- Pregnancy
- Patients with upper gastrointestinal (GI) abnormalities such as hiatal hernia and gastric tumors
- Patients with a recent history of upper GI bleeding (within the last 12 months), previous stomach and esophagus surgeries, or abnormal anatomy of the upper gastrointestinal tract
- Patients using medications that affect gastric motility or other related conditions
- Patients with uncontrolled diabetes
- Patients who require emergency surgery
- Patients with advanced cardiac, renal, pulmonary, or hepatic failure
- Patients who refuse to participate and do not provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatih Sultan Mehmet Training and Research Hospital
Istanbul, Istanbul, 34752, Turkey (Türkiye)
Related Publications (11)
Sherwin M, Katz D. Using gastric ultrasound to assess gastric content in the pregnant patient. BJA Educ. 2021 Nov;21(11):404-407. doi: 10.1016/j.bjae.2021.08.001. Epub 2021 Sep 23. No abstract available.
PMID: 34707884BACKGROUNDMoake MM, Presley BC, Hill JG, Wolf BJ, Kane ID, Busch CE, Jackson BF. Point-of-Care Ultrasound to Assess Gastric Content in Pediatric Emergency Department Procedural Sedation Patients. Pediatr Emerg Care. 2022 Jan 1;38(1):e178-e186. doi: 10.1097/PEC.0000000000002198.
PMID: 32769837BACKGROUNDSmith I, Kranke P, Murat I, Smith A, O'Sullivan G, Soreide E, Spies C, in't Veld B; European Society of Anaesthesiology. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011 Aug;28(8):556-69. doi: 10.1097/EJA.0b013e3283495ba1.
PMID: 21712716BACKGROUNDBouvet L, Desgranges FP, Aubergy C, Boselli E, Dupont G, Allaouchiche B, Chassard D. Prevalence and factors predictive of full stomach in elective and emergency surgical patients: a prospective cohort study. Br J Anaesth. 2017 Mar 1;118(3):372-379. doi: 10.1093/bja/aew462.
PMID: 28203726BACKGROUNDMahajan V, Hashmi J, Singh R, Samra T, Aneja S. Comparative evaluation of gastric pH and volume in morbidly obese and lean patients undergoing elective surgery and effect of aspiration prophylaxis. J Clin Anesth. 2015 Aug;27(5):396-400. doi: 10.1016/j.jclinane.2015.03.004. Epub 2015 Apr 30.
PMID: 25935831BACKGROUNDPerlas A, Chan VW, Lupu CM, Mitsakakis N, Hanbidge A. Ultrasound assessment of gastric content and volume. Anesthesiology. 2009 Jul;111(1):82-9. doi: 10.1097/ALN.0b013e3181a97250.
PMID: 19512861BACKGROUNDSinghal V, Youssef S, Misra M. Use of sleeve gastrectomy in adolescents and young adults with severe obesity. Curr Opin Pediatr. 2020 Aug;32(4):547-553. doi: 10.1097/MOP.0000000000000927.
PMID: 32692052BACKGROUNDAaseth J, Ellefsen S, Alehagen U, Sundfor TM, Alexander J. Diets and drugs for weight loss and health in obesity - An update. Biomed Pharmacother. 2021 Aug;140:111789. doi: 10.1016/j.biopha.2021.111789. Epub 2021 May 31.
PMID: 34082399BACKGROUNDRuban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond). 2019 May;19(3):205-212. doi: 10.7861/clinmedicine.19-3-205.
PMID: 31092512BACKGROUNDDe Lorenzo A, Gratteri S, Gualtieri P, Cammarano A, Bertucci P, Di Renzo L. Why primary obesity is a disease? J Transl Med. 2019 May 22;17(1):169. doi: 10.1186/s12967-019-1919-y.
PMID: 31118060BACKGROUNDSchetz M, De Jong A, Deane AM, Druml W, Hemelaar P, Pelosi P, Pickkers P, Reintam-Blaser A, Roberts J, Sakr Y, Jaber S. Obesity in the critically ill: a narrative review. Intensive Care Med. 2019 Jun;45(6):757-769. doi: 10.1007/s00134-019-05594-1. Epub 2019 Mar 19.
PMID: 30888440BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ARZU YILDIRIM AR, Associate Professor
Fatih Sultan Mehmet Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant MD
Study Record Dates
First Submitted
May 19, 2025
First Posted
June 22, 2025
Study Start
June 30, 2024
Primary Completion
January 15, 2026
Study Completion
April 15, 2026
Last Updated
June 22, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share